Adagio Medical Holdings (ADGM) Common Equity (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Common Equity data on file, last reported at $5.7 million in Q1 2026.

• Common Equity for Q1 2026 came in at $5.7 million, down 53.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.7 million (down 53.83% YoY), and the FY2025 annual result was $12.4 million, down 37.72% from the prior year.
• Common Equity eased to $5.7 million in Q1 2026 per ADGM's latest filing, from $12.4 million in the prior quarter.
• Over five years, Common Equity peaked at $76.6 million in Q3 2024 and troughed at -$140.5 million in Q2 2024.
• A 4-year average of -$36.4 million and a median of $5.7 million in 2026 frame the typical range for Common Equity.
• The sharpest annual moves came in 2024 and 2025: Common Equity surged 161.99% in 2024, then slumped 101.71% in 2025.
• A 4-year view of Common Equity shows it stood at -$132.0 million in 2023, then soared by 115.08% to $19.9 million in 2024, then plunged by 37.72% to $12.4 million in 2025, then slumped by 53.84% to $5.7 million in 2026.
• Business Quant data shows ADGM's Common Equity at $5.7 million in Q1 2026, $12.4 million in Q4 2025, and -$1.3 million in Q3 2025.